Volume 20, Number 7—July 2014
Synopsis
Epidemiology, Clinical Manifestations, and Outcomes of Streptococcus suis Infection in Humans
Table 4
Summary rates of the main clinical outcomes among patients with Streptococcus suis infection included in a systematic review
Variable | Single-case dataset, n = 174 | Large studies, median (range) | Meta-analysis, pooled mean (95% CI) | No. studies meta-analyzed* |
---|---|---|---|---|
Death | 10.3 | 8.9 (0.0–56.0) | 12.8 (9.0–18.0) | 25 |
Hearing loss† | 44.8 | 38.7 (6.0–100) | 39.1 (31.0–47.8) | 26 |
Recovery from hearing loss | ‡ | 5.0 (0.0–52.3) | 15.4 (5.3–37.3) | 8 |
Vestibular dysfunction§ | 16.7 | 25.0 (3.3–60.0) | 22.7 (15.6–32.0) | 13 |
Visual impairment | 4.0 | – | –¶ | – |
*Includes the single-case dataset and the large studies (Technical Appendix Table 2).
†Studies included if case-patients were reported to have any degree of hearing impairment (unilateral or bilateral, temporary or permanent).
‡Reliable data could not be extracted for the majority of the case reports.
§Studies included if case-patients were reported to have ataxia, vertigo, loss of balance, or vestibular dysfunction.
¶Dashes indicate not applicable because no large study reported these data.
1These authors contributed equally to this article.